Alzheimer's disease and other dementias: advances in 2013. (Q38170692)

30 August 2017

title

Alzheimer's disease and other dementias: advances in 2013. (English)

1 reference

30 August 2017

0 references

1

Eric M Reiman

1 reference

30 August 2017

publication date

1 January 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

13

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

3-5

1 reference

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(13)70257-6

7 January 2021

Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(13)70257-6

7 January 2021

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(13)70257-6

7 January 2021

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(13)70257-6

7 January 2021

Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(13)70257-6

7 January 2021

Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(13)70257-6

7 January 2021

Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(13)70257-6

7 January 2021

Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(13)70257-6

7 January 2021

Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo.

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(13)70257-6

7 January 2021

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(13)70257-6

7 January 2021

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(13)70257-6

7 January 2021

TREM2 Variants in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(13)70257-6

7 January 2021

Regulatory innovation and drug development for early-stage Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(13)70257-6

7 January 2021

10.1016/S1474-4422(13)70257-6

Identifiers

DOI

1 reference

30 August 2017

1 reference